/
AEON
$0.74+$0.02 (+2.44%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$19.0M
26M shares
52-week range
$0.51 – $1.45
24% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
XASE
CS
Borrow rate
5.81%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-661.66
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $3.4M | $2.5M | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $1.0K | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $3.4M | $2.5M | $0 | $0 | $0 | $0 | $0 |
| Gross margin | 100.0% | 100.0% | — | — | — | — | — |
| R&D | $4.8M | $7.3M | $25.7M | $34.8M | $33.0M | $14.2M | $4.1M |
| Operating income | −$54.0M | −$16.4M | −$65.8M | −$48.4M | −$348.1M | $73.0M | −$12.8M |
| EBITDA | −$47.5M | −$15.5M | −$36.9M | −$52.5M | −$52.7M | −$27.7M | −$16.2M |
| Net income | $172.9M | −$32.9M | −$55.6M | −$52.6M | −$384.6M | $42.0M | −$39.2M |
| Net margin | 5151.0% | -1307.1% | — | — | — | — | — |
| EPS (diluted) | 1481.04 | -547.60 | -31.73 | -27.25 | -4.99 | 72.93 | -3.95 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $16M | $-1.05 | $-1.05–$-1.05 | 1 |
| 2027 | $2M | $-30.24 | $-30.24–$-30.24 | 1 |
| 2028 | $88M | $16.56 | $16.56–$16.56 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
AEON Biopharma, Inc.
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
www.aeonbiopharma.com- Employees
- 8
- IPO / List date
- Jul 24, 2023
- HQ
- IRVINE, CA
Held by traders on TradeandTell
No one on the platform currently holds AEON.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in AEON as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-02-26 | 1-for-72reverse |
Recent trades on TradeandTell
No one on the platform has traded AEON yet.
